{"id":"https://openalex.org/W2166566481","doi":"https://doi.org/10.1158/1535-7163.mct-13-0323","title":"APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc\u03b3 Receptors","display_name":"APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc\u03b3 Receptors","alternate_titles":[],"publication_year":2013,"publication_date":"2013-12-01","ids":{"openalex":"https://openalex.org/W2166566481","doi":"https://doi.org/10.1158/1535-7163.mct-13-0323","mag":"2166566481","pmid":"https://pubmed.ncbi.nlm.nih.gov/24101228"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-13-0323","doi":"https://doi.org/10.1158/1535-7163.mct-13-0323","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0323","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2166566481"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053232413","display_name":"Christian Gieffers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Gieffers","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103194954","display_name":"Michael Kluge","orcid":"https://orcid.org/0000-0002-5733-6133","observed_orcids":["https://orcid.org/0000-0002-5733-6133"]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Kluge","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christian Merz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Merz","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108623886","display_name":"Jaromir Sykora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jaromir Sykora","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109340436","display_name":"Meinolf Thiemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meinolf Thiemann","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065965268","display_name":"Ren\u00e9 Schaal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ren\u00e9 Schaal","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109154220","display_name":"Carmen Fischer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carmen Fischer","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063456411","display_name":"Marcus Bransch\u00e4del","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcus Bransch\u00e4del","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046081794","display_name":"Behnaz Ahangarian Abhari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Behnaz Ahangarian Abhari","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046601855","display_name":"Peter Hohenberger","orcid":"https://orcid.org/0000-0001-5359-5923","observed_orcids":["https://orcid.org/0000-0001-5359-5923"]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Hohenberger","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080913590","display_name":"Simone Fulda","orcid":"https://orcid.org/0000-0002-0459-6417","observed_orcids":["https://orcid.org/0000-0002-0459-6417"]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simone Fulda","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024872255","display_name":"Harald Fricke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harald Fricke","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013217770","display_name":"Oliver Hill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Oliver Hill","raw_affiliation_strings":["Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Apogenix GmbH, Im Neuenheimer Feld, Heidelberg; 2Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt; and 3Division of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"]},{"raw_affiliation_string":"Institute for Experimenal Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt","institution_ids":["https://openalex.org/I114090438"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013217770"],"corresponding_institution_ids":["https://openalex.org/I114090438","https://openalex.org/I223822909"],"apc_list":null,"apc_paid":null,"fwci":2.4516,"has_fulltext":false,"cited_by_count":128,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90601407,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"12","issue":"12","first_page":"2735","last_page":"2747"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.03009999915957451,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trail-receptor-agonists","display_name":"TRAIL receptor agonists","score":0.9010000228881836},{"id":"https://openalex.org/keywords/receptor-clustering","display_name":"receptor clustering","score":0.7760000228881836},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/colorectal-cancer-xenografts","display_name":"colorectal cancer xenografts","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.7139080762863159},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5687720775604248},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5549008250236511},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5479554533958435},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5149191617965698},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.5127785801887512},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48029252886772156},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.45744746923446655},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.43414780497550964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4237653911113739},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3394240140914917},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3219906985759735},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3062611222267151},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30040034651756287},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2009488046169281},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19901517033576965},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.145056813955307},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07369741797447205},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06942471861839294}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1158/1535-7163.mct-13-0323","doi":"https://doi.org/10.1158/1535-7163.mct-13-0323","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0323","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:24101228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24101228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.835.8125","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.835.8125","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/12/12/2735.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.838.9968","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.838.9968","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/early/2013/11/22/1535-7163.MCT-13-0323.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.853.5578","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.853.5578","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/early/2013/10/05/1535-7163.MCT-13-0323.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1484817497","https://openalex.org/W1901785997","https://openalex.org/W1910698471","https://openalex.org/W1964304371","https://openalex.org/W1967051322","https://openalex.org/W1974144614","https://openalex.org/W1985355814","https://openalex.org/W1987506447","https://openalex.org/W1991388076","https://openalex.org/W1996408040","https://openalex.org/W2005246279","https://openalex.org/W2011684044","https://openalex.org/W2023342930","https://openalex.org/W2030932286","https://openalex.org/W2034274579","https://openalex.org/W2037978214","https://openalex.org/W2056217426","https://openalex.org/W2062853648","https://openalex.org/W2068766896","https://openalex.org/W2070645153","https://openalex.org/W2074106785","https://openalex.org/W2087590198","https://openalex.org/W2098715950","https://openalex.org/W2106284224","https://openalex.org/W2107610558","https://openalex.org/W2117087670","https://openalex.org/W2126277558","https://openalex.org/W2130988210","https://openalex.org/W2133221875","https://openalex.org/W2133283258","https://openalex.org/W2137276707","https://openalex.org/W2148342786","https://openalex.org/W2156330379","https://openalex.org/W2163825070"],"related_works":["https://openalex.org/W1998341680","https://openalex.org/W1998350721","https://openalex.org/W1998792320","https://openalex.org/W2505170463","https://openalex.org/W2913578542","https://openalex.org/W2099932018","https://openalex.org/W2092307090"],"abstract_inverted_index":{"Cancer":[0],"cells":[1],"can":[2],"be":[3],"specifically":[4],"driven":[5],"into":[6],"apoptosis":[7,46,197],"by":[8,48,165],"activating":[9],"Death-receptor-4":[10],"(DR4;":[11],"TRAIL-R1)":[12],"and/or":[13],"Death-receptor-5":[14],"(DR5;":[15],"TRAIL-R2).":[16],"Albeit":[17],"showing":[18],"promising":[19],"preclinical":[20],"efficacy,":[21],"first-generation":[22],"protein":[23,147],"therapeutics":[24],"addressing":[25],"this":[26,92,160],"pathway,":[27],"especially":[28],"agonistic":[29,49,242],"anti-DR4/DR5-monoclonal":[30],"antibodies,":[31],"have":[32],"not":[33],"been":[34],"clinically":[35],"successful":[36],"to":[37,40,59,67,72,176,241],"date.":[38],"Due":[39],"their":[41,68],"bivalent":[42],"binding":[43,63,134,151,184],"mode,":[44],"effective":[45,73],"induction":[47],"TRAIL-R":[50],"antibodies":[51,97],"is":[52,106,163,192],"achieved":[53,164],"only":[54],"upon":[55],"additional":[56],"events":[57],"leading":[58],"antibody-multimer":[60],"formation.":[61],"The":[62,78,100],"of":[64,88,103,110,156,159,169,196,210,233,244],"these":[65,104],"multimers":[66],"target":[69],"subsequently":[70],"leads":[71],"receptor-clustering":[74],"on":[75,84,198],"cancer":[76],"cells.":[77,206],"research":[79],"results":[80],"presented":[81],"here":[82],"report":[83],"a":[85,107,145,149,170,193,218],"new":[86],"class":[87],"TRAIL-receptor":[89],"agonists":[90,105],"overcoming":[91],"intrinsic":[93],"limitation":[94],"observed":[95,229],"for":[96],"in":[98,115,140,144,230],"general.":[99],"main":[101],"feature":[102],"TRAIL-mimic":[108],"consisting":[109],"three":[111,132],"TRAIL-protomer":[112],"subsequences":[113],"combined":[114],"one":[116],"polypeptide":[117],"chain,":[118],"termed":[119],"the":[120,126,154,167,177,228,234],"single-chain":[121],"TRAIL-receptor-binding":[122],"domain":[123],"(scTRAIL-RBD).":[124],"In":[125,153,189,207],"active":[127],"compounds,":[128],"two":[129],"scTRAIL-RBDs":[130],"with":[131,148,215],"receptor":[133,183],"sites":[135,185],"each":[136],"are":[137],"brought":[138],"molecularly":[139],"close":[141],"proximity":[142],"resulting":[143],"fusion":[146,237],"hexavalent":[150,235],"mode.":[152],"case":[155],"APG350-the":[157],"prototype":[158],"engineering":[161],"concept-this":[162],"fusing":[166],"Fc-part":[168],"human":[171,199],"immunoglobulin":[172],"G1":[173],"(IgG1)-mutein":[174],"C-terminally":[175],"scTRAIL-RBD":[178,236],"polypeptide,":[179],"thereby":[180],"creating":[181],"six":[182],"per":[186],"drug":[187],"molecule.":[188],"vitro,":[190],"APG350":[191,216],"potent":[194],"inducer":[195],"tumor":[200,205],"cell":[201],"lines":[202],"and":[203],"primary":[204],"vivo,":[208],"treatment":[209],"mice":[211],"bearing":[212],"Colo205-xenograft":[213],"tumors":[214],"showed":[217],"dose-dependent":[219],"antitumor":[220],"efficacy.":[221],"By":[222],"dedicated":[223],"muteins,":[224],"we":[225],"confirmed":[226],"that":[227],"vivo":[231],"efficacy":[232],"proteins":[238],"is-in":[239],"contrast":[240],"antibodies-independent":[243],"Fc\u03b3R-based":[245],"cross-linking":[246],"events.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2166566481","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
